There are 2867 resources available
Five years of FDA approvals (2017-2022): A report from the ESMO-MCBS
Presenter: Nathan Cherny
Session: 5-year impact of new registered indications on the ESMO-MCBS
Resources:
Slides
Webcast
The impact of COVID-19 on patient-physician communication and the role of telemedicine
Presenter: Ivica Ratosa
Session: The impact of COVID-19 on patients with cancer: Lessons learnt and pathway for the future
Resources:
Slides
Webcast
HER2+ advanced breast cancer
Presenter: Shanu Modi
Session: Updates in the standard of care of metastatic breast cancer
Resources:
Slides
Webcast
Next generation synthetic lethal target discovery using high-throughput CRISPR technology
Presenter: Matthew Garnett
Session: Exploiting synthetic lethality: The next generation
Resources:
Slides
Webcast
Targeting the uncommon molecular alterations
Presenter: Andrea Sartore Bianchi
Session: Are novel immunotherapeutics and targeted treatments going to transform the management of CRC?
Resources:
Slides
Webcast
PET: New applications
Presenter: Marius Mayerhoefer
Session: How diagnostic tools impact therapy of haematological malignancies
Resources:
Slides
Webcast
Mucosal melanoma
Presenter: Jessica Hassel
Session: Advances in non-cutaneous melanoma
Resources:
Slides
Webcast
Neuroendocrine disease: Molecular data and new models
Presenter: Himisha Beltran
Session: Using molecular data that impacts clinical practice
Resources:
Slides
Webcast
Organ-specific tumour microenvironment
Presenter: Adil Daud
Session: How the tumour microenvironment affects outcome and therapy response?
Resources:
Slides
Webcast
New drugs for ultrarare sarcoma
Presenter: Silvia Stacchiotti
Session: Ultra-rare sarcoma: Navigating an endless sea
Resources:
Slides
Webcast